![Raj Dua](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raj Dua
Direttore/Membro del Consiglio presso Abacus Bioscience, Inc.
Profilo
Raj Dua is currently working as a Director at Abacus Bioscience, Inc. and as a Chemistry, Manufacturing & Controls Manager at Resolve Therapeutics LLC.
Previously, he worked as a Director-Assay Development & Process Validation at Xcyte Therapies, Inc., a Senior Director-Product Development at Emergent Product Development Seattle, and a Vice President-Pharmaceutical Operations at Lundbeck Seattle BioPharmaceuticals, Inc. Dr. Dua holds an MBA degree from the University of Washington and a doctorate degree from the University of Georgia.
Posizioni attive di Raj Dua
Società | Posizione | Inizio |
---|---|---|
Resolve Therapeutics LLC
![]() Resolve Therapeutics LLC BiotechnologyHealth Technology Resolve Therapeutics LLC operates as a biotechnology company. It engages in the development of biotechnology drugs. The firm specializes in treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematous and Sjogren’s syndrome. The company was founded by James Posada in 2010 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Abacus Bioscience, Inc.
![]() Abacus Bioscience, Inc. BiotechnologyHealth Technology Abacus Bioscience, Inc. develops developing novel immunotherapeutic treatments for cancer and antiviral diseases. The company was founded by Edward A Clark and Craig W Philips and is headquartered in Seattle, WA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Raj Dua
Società | Posizione | Fine |
---|---|---|
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Xcyte Therapies, Inc. | Corporate Officer/Principal | - |
ALDER BIOPHARMACEUTICALS, INC. | Direttore operativo | - |
Formazione di Raj Dua
University of Washington | Masters Business Admin |
University of Georgia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Xcyte Therapies, Inc. | Health Technology |
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
![]() Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Resolve Therapeutics LLC
![]() Resolve Therapeutics LLC BiotechnologyHealth Technology Resolve Therapeutics LLC operates as a biotechnology company. It engages in the development of biotechnology drugs. The firm specializes in treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematous and Sjogren’s syndrome. The company was founded by James Posada in 2010 and is headquartered in Seattle, WA. | Health Technology |
Abacus Bioscience, Inc.
![]() Abacus Bioscience, Inc. BiotechnologyHealth Technology Abacus Bioscience, Inc. develops developing novel immunotherapeutic treatments for cancer and antiviral diseases. The company was founded by Edward A Clark and Craig W Philips and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Raj Dua